文献速递乳腺胸部CTMR乳腺X线

对比增强胸部光子计数CT与数字乳腺X线摄影对乳腺癌机会性局部区域分期的诊断准确性:一项前瞻性试验

Diagnostic Accuracy of Contrast-Enhanced Thoracic Photon-Counting Computed Tomography for Opportunistic Locoregional Staging of Breast Cancer Compared With Digital Mammography: A Prospective Trial.
PubMed 文献 · Invest Radiol · 2023-12-01

该前瞻性临床队列研究纳入32例新诊断乳腺癌女性,对比增强胸部光子计数CT(PC-CT)与数字乳腺X线摄影(DM)对照MRI联合病理/临床数据的参考标准,评估局部区域分期诊断性能。PC-CT的T分期诊断准确性高于DM(0.94 vs 0.50,P < 0.01),对相邻导管原位癌的敏感度和特异度均显著优于DM,观察者间可靠性也更高。

要点

  • PC-CT对乳腺癌T分期的诊断准确性高于DM(0.94 vs 0.50,P < 0.01)。
  • PC-CT检测相邻DCIS的敏感度0.83、特异度0.99,均显著优于DM(P < 0.04)。
  • PC-CT观察者间可靠性κ均值0.88,高于DM的0.54(P = 0.01)。

核心结论

  • 光子计数CT在T分期和相邻DCIS检测方面优于数字乳腺X线摄影,对比增强胸部PC-CT用于乳腺癌机会性局部区域分期是可行的,可能克服DM的局限性并有望改善患者管理。

研究设计与样本

  • 前瞻性临床队列研究,6个月内纳入32例新诊断乳腺癌女性(平均年龄59 ± 13.0岁),均行俯卧位对比增强胸部PC-CT和乳腺MRI;2名放射科医师在盲法下独立评估PC-CT和DM的6项特征;参考标准由独立裁决委员会依据MRI共识阅片结合全部组织病理/临床数据、采用TNM第八版生成。

关键影像表现/征象

  • PC-CT评估的6项特征包括最大肿块病灶直径、皮肤/胸肌/胸壁浸润、肿块病灶数目、相邻DCIS存在与否、肿瘤可见度和诊断信心。
  • PC-CT检测到的肿瘤肿块数目与参考标准的相关性(0.72)强于DM(0.50),P < 0.01。
  • PC-CT的观察者间可靠性κ均值0.88,高于DM的0.54(P = 0.01)。

诊断标准与关键数值

  • T分期诊断准确性:PC-CT 0.94 vs DM 0.50(P < 0.01)。
  • 相邻DCIS检测敏感度:PC-CT 0.83 vs DM 0.25;特异度:PC-CT 0.99 vs DM 0.80(P < 0.04)。
  • 肿瘤肿块数目与参考标准的相关性:PC-CT 0.72 vs DM 0.50(P < 0.01)。
  • 观察者间可靠性κ均值:PC-CT 0.88 vs DM 0.54(P = 0.01)。

临床应用与阅片要点

  • 对比增强胸部PC-CT可在胸部CT分期时机会性完成乳腺癌局部区域分期,T分期准确性高于DM。
  • PC-CT对相邻DCIS的检测敏感度和特异度均显著优于DM,报告时可关注瘤周DCIS征象。
  • PC-CT观察者间可靠性较高(κ均值0.88),提示其评估结果在不同阅片者间一致性较好。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Accurate locoregional staging is crucial for effective breast cancer treatment. Photon-counting computed tomography (PC-CT) is an emerging technology with high spatial resolution and the ability to depict uptake of contrast agents in tissues, making it a promising tool for breast cancer imaging. The aim of this study was to establish the feasibility of locoregional staging of breast cancer through contrast-enhanced thoracic PC-CT, assess its diagnostic performance, and compare it with that of digital mammography (DM).

MATERIALS AND METHODS: Patients with newly diagnosed breast cancer, DM, and indication of thoracic CT staging were prospectively enrolled in this clinical cohort study over a period of 6 months. Participants underwent contrast-enhanced thoracic PC-CT and breast magnetic resonance imaging in prone position. After blinding to patient data, 2 radiologists independently rated PC-CT and DM regarding the following 6 characteristics: (1) diameter of the largest mass lesion, (2) infiltration of cutis/pectoral muscle/thoracic wall, (3) number of mass lesions, (4) presence/absence of adjacent ductal carcinoma in situ (DCIS), (5) tumor conspicuity, and (6) diagnostic confidence. Reference standard was generated from consensus reading of magnetic resonance imaging combined with all histopathological/clinical data by an independent adjudication committee applying TNM eighth edition.

RESULTS: Among 32 enrolled female subjects (mean ± SD age, 59 ± 13.0 years), diagnostic accuracy for T-classification was higher for PC-CT compared with DM (0.94 vs 0.50, P < 0.01). Moreover, the correlation of the number of detected tumor masses with the reference standard was stronger for PC-CT than for DM (0.72 vs 0.50, P < 0.01). We observed that PC-CT significantly ( P < 0.04) outperformed DM regarding not only sensitivity (0.83 and 0.25, respectively) but also specificity (0.99 and 0.80, respectively) for adjacent DCIS. The κ values for interreader reliability were higher for PC-CT compared with DM (mean 0.88 vs 0.54, respectively; P = 0.01).

CONCLUSIONS: Photon-counting computed tomography outperformed DM in T-classification and provided higher diagnostic accuracy for the detection of adjacent DCIS. Therefore, opportunistic locoregional staging of breast cancer in contrast-enhanced thoracic PC-CT is feasible and could overcome limitations of DM with the potential to improve patient management.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Neubauer J, Wilpert C, Gebler O, et al. Diagnostic Accuracy of Contrast-Enhanced Thoracic Photon-Counting Computed Tomography for Opportunistic Locoregional Staging of Breast Cancer Compared With Digital Mammography: A Prospective Trial. Invest Radiol. 2023. PMID: 38038693. doi:10.1097/RLI.0000000000001051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。